IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

LUZZAGO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.139
AS - Asia 7.663
NA - Nord America 6.618
SA - Sud America 857
AF - Africa 232
OC - Oceania 78
Continente sconosciuto - Info sul continente non disponibili 3
Totale 24.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.286
DE - Germania 4.580
SG - Singapore 2.351
CN - Cina 2.130
IT - Italia 1.521
HK - Hong Kong 798
BD - Bangladesh 729
SE - Svezia 666
BR - Brasile 663
RU - Federazione Russa 545
VN - Vietnam 536
GB - Regno Unito 511
FR - Francia 374
IN - India 324
CA - Canada 212
IE - Irlanda 196
NL - Olanda 169
FI - Finlandia 132
ID - Indonesia 129
JP - Giappone 124
CI - Costa d'Avorio 90
TR - Turchia 89
KR - Corea 77
PH - Filippine 67
MX - Messico 63
AU - Australia 62
AR - Argentina 59
ES - Italia 58
IQ - Iraq 57
DK - Danimarca 53
PL - Polonia 51
AT - Austria 42
UA - Ucraina 40
BE - Belgio 38
CH - Svizzera 35
EC - Ecuador 30
ZA - Sudafrica 30
MA - Marocco 28
SA - Arabia Saudita 26
EG - Egitto 25
PE - Perù 24
MY - Malesia 23
CO - Colombia 22
PK - Pakistan 20
AE - Emirati Arabi Uniti 19
TW - Taiwan 18
VE - Venezuela 18
CL - Cile 17
RO - Romania 16
IR - Iran 15
CZ - Repubblica Ceca 14
IL - Israele 14
NZ - Nuova Zelanda 14
PT - Portogallo 14
TN - Tunisia 14
UZ - Uzbekistan 14
NP - Nepal 13
TH - Thailandia 13
AZ - Azerbaigian 12
KE - Kenya 12
PY - Paraguay 12
NG - Nigeria 10
NO - Norvegia 10
JO - Giordania 9
TT - Trinidad e Tobago 9
AL - Albania 8
KG - Kirghizistan 8
RS - Serbia 8
CR - Costa Rica 7
GT - Guatemala 7
HU - Ungheria 7
JM - Giamaica 7
KZ - Kazakistan 7
LT - Lituania 7
BG - Bulgaria 6
GR - Grecia 6
LU - Lussemburgo 6
OM - Oman 6
PA - Panama 6
UY - Uruguay 6
BO - Bolivia 5
BY - Bielorussia 5
HN - Honduras 5
LA - Repubblica Popolare Democratica del Laos 5
PS - Palestinian Territory 5
AM - Armenia 4
GH - Ghana 4
HR - Croazia 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
BF - Burkina Faso 3
BH - Bahrain 3
CG - Congo 3
CU - Cuba 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
LK - Sri Lanka 3
PR - Porto Rico 3
Totale 24.549
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 4.254
Singapore 1.292
Ashburn 945
Chandler 729
Hong Kong 649
Dallas 594
San Jose 565
Milan 535
Beijing 347
Southend 312
Council Bluffs 264
New York 233
Hefei 219
Los Angeles 216
Princeton 200
Dublin 186
Santa Clara 184
Ho Chi Minh City 157
Buffalo 142
Lauterbourg 142
Hanoi 120
Bengaluru 105
Rome 103
Moscow 100
Guangzhou 93
Abidjan 90
Jakarta 90
Tokyo 83
Helsinki 80
São Paulo 79
Wilmington 75
Shanghai 74
Boardman 73
Des Moines 70
Montreal 70
Columbus 66
Fairfield 65
Toronto 63
Munich 59
Naples 58
Phoenix 53
Berlin 50
Seoul 48
Houston 45
Hyderabad 43
Ann Arbor 42
Cangzhou 42
Istanbul 42
Seattle 41
Turin 41
Dearborn 38
Shenzhen 38
Nuremberg 37
Cambridge 34
Chicago 34
Brussels 33
London 33
Orem 33
The Dalles 32
Tianjin 30
Nanjing 27
San Francisco 26
Sydney 26
Lappeenranta 25
Zhengzhou 25
Atlanta 24
Turku 23
Amsterdam 22
Bari 22
Changsha 22
Warsaw 22
Da Nang 21
Jinan 21
Dong Ket 20
Shenyang 20
Baghdad 19
Lima 19
Woodbridge 19
Boston 18
Bühl 18
Düsseldorf 18
Wuhan 18
Brooklyn 17
Rio de Janeiro 17
San Diego 17
Vienna 17
Bologna 16
Genoa 16
Haiphong 16
Mumbai 16
Redwood City 16
Washington 16
Catania 15
Zurich 15
Dhaka 14
Auckland 13
Brasília 13
Charlotte 13
Chennai 13
Chongqing 13
Totale 15.318
Salva come PNG Salva come JPEG
Nome #
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 475
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 352
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 344
REPEATED MRI SCANS DURING ACTIVE SURVEILLANCE FOR PROSTATE CANCER: NATURAL HISTORY OF PROSTATIC LESIONS AND UPGRADING RATES OVER TIME 332
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 331
Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer 301
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 296
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 294
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 293
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 293
High-performance prediction models for prostate cancer radiomics 287
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies : Time to Improve Radiologists’ Training Program? 285
Small renal masses with tumor size 0 to 2 cm : A SEER-based study and validation of NCCN guidelines 268
Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma 265
Long-term follow‐up outcomes after percutaneous us/ct‐guided radiofrequency ablation for ct1a‐b renal masses : Experience from single high‐volume referral center 262
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 256
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging 255
A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor 252
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 251
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 248
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 245
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling 244
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 242
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 238
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 237
Robot-assisted intracorporeal orthotopic ileal neobladder : Description of the “shell” technique 233
Penile-Sparing Surgery for Tumour Recurrence after Previous Glansectomy/Partial Penectomy: Treatment Feasibility and Oncological Outcomes 229
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 228
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 228
Quality assurance for automatically generated contours with additional deep learning 225
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 224
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial 220
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 218
Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score 217
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy 215
Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy : results from a large multicenter international collaboration 215
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 210
Thulium–yttrium–aluminium–garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life 209
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort 209
Robot-assisted Resection of a Wide-extending Abdominoperineal Angiomyofibroblastoma in a Male Patient 206
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract 203
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 202
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 202
PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions 198
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 197
Robot-Assisted Radical Cystectomy for Nonmetastatic Urothelial Carcinoma of Urinary Bladder: A Comparison between Intracorporeal Versus Extracorporeal Orthotopic Ileal Neobladder 195
The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases: A case report 194
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma 189
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 189
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 188
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes 186
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 186
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size : A population-based study 184
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 184
Thermal ablation for small renal masses: Identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes 183
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy 182
Oligo metastatic renal cell carcinoma : stereotactic body radiation therapy, if, when and how? 181
Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone 180
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 178
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates 177
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma 177
Penile-sparing surgery for patients with superficial or initially invasive squamous cell carcinoma of the penis : long-term oncological outcomes 177
A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients 176
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract 173
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 172
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 172
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer 170
A Phase 3 Prospective Randomized Trial to Evaluate the Impact of Augmented Reality During Robot-assisted Radical Prostatectomy on the Rates of Postoperativane Surgical Margins: A Clinical Trial Protocol 170
What is the best time for postoperative radiation therapy in pN1 prostate cancer? 169
Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years 166
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models 165
Medical Expulsive Therapy for Symptomatic Distal Ureter Stones: Is the Combination of Bromelain and Tamsulosin More Effective than Tamsulosin Alone? Preliminary Results of a Single-Center Study 165
Radiomics in prostate cancer: an up-to-date review 165
Impact of Perioperative Immunonutrition on Complications in Patients Undergoing Radical Cystectomy: A Retrospective Analysis 163
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center 161
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 159
Uro-oncologic patient management during the COVID-19 pandemic: Survey findings from an Italian oncologic hub 159
Effect of allogeneic intraoperative blood transfusion on survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution 159
A PHASE III PROSPECTIVE RANDOMIZED TRIAL TO EVALUATE THE IMPACT OF AUGMENTED REALITY DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY ON THE RATES OF POSTOPERATIVE SURGICAL MARGINS 156
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 151
Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomes 150
Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy 148
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma 147
Prognostic factors in patients with small renal masses : a comparison between <2 vs. 2.1–4 cm renal cell carcinomas 147
The Clinical Role of SRSF1 Expression in Cancer: A Review of the Current Literature 146
Effect on postoperative survival of the status of distal ureteral margin: The necessity to achieve negative margins at the time of radical cystectomy 146
The effect of sex on disease stage and survival after radical cystectomy : a population-based analysis 145
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma : a population-based study 141
Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomes 139
The Effect of Surgical Resection on Cancer-Specific Mortality in Pelvic Soft Tissue Sarcoma According to Histologic Subtype and Stage 138
Prostate cancer grade and stage misclassification in active surveillance candidates : Black versus white patients 138
Long-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patients 137
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study 137
Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder 136
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years : A population-based analysis 136
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies 136
Thulium laser treatment of upper urinary tract carcinoma: A multi-institutional analysis of surgical and oncological outcomes 136
Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives 135
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 135
In-hospital length of stay after major surgical oncological procedures 133
Totale 20.341
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/20221.841 47 52 39 37 407 108 65 101 188 117 106 574
2022/20232.321 279 291 207 194 186 329 118 151 265 36 204 61
2023/20244.310 97 108 105 126 354 213 638 534 291 515 652 677
2024/20255.504 609 598 511 499 368 292 217 419 267 378 443 903
2025/202610.314 1.031 860 1.134 843 824 566 1.182 461 890 668 1.420 435
Totale 25.324